Tripath Talking To Pharma, Aims For Companion Diagnostic As Early As 2006
This article was originally published in The Gray Sheet
Executive Summary
Tripath Imaging could sign an agreement with a pharmaceutical company during the first half of this year to develop companion diagnostics
You may also be interested in...
Roche Amplicor HPV Test To Battle With Digene: A David & Goliath Scenario?
Roche Diagnostics' plan to obtain a CE mark by the second quarter for its Amplicor human papillomavirus PCR-based test and complete U.S. trials by Q2 2005 has Digene scurrying to maintain its DNAwithPap first-to-market advantage
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.